Market Cap: $42.49B
Market Cap: $42.49B
Open
$202.79
Prev. Close
$257.60
High
$207.35
Low
$201.98
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific.
IQVIA Holdings Inc. trades on the New York Stock Exchange under the ticker IQV, priced in USD.
IQVIA Holdings Inc. has a market capitalisation of $42.49B, based on its latest share price.
IQV trades at 31.06 times its trailing 12-month earnings.
Over the past 52 weeks IQV has traded between $154.50 and $284.50.
No. IQVIA Holdings Inc. does not currently pay a dividend.
Profitable, with a net margin of 8.1% over the last 12 months.
The analyst consensus rating for IQV is Buy. Analysts' average 12-month price target of $258.75 implies 0% upside.
Ari Bousbib is the CEO of IQVIA Holdings Inc., which is headquartered in Durham.
Generated automatically from reported financial data. General information only, not financial advice.

IQVIA Holdings Inc. ( IQV ) stands at the forefront of the healthcare technology landscape, positioned uniquely to leverage its extensive data capabilities and industry insights. As the global leader…
Charles River Laboratories Initiates Strategic Divestiture to Enhance Core Operations Charles River Laboratories, a key player in the biotechnology and pharmaceutical sectors, announces a significant…
Charles River Laboratories Restructures for Core Focus and Growth In a significant strategic realignment, Charles River Laboratories (NYSE: CRL) announces its plan to divest certain segments of its bu…
AI Revolution: A Shift Toward Practical Applications As the artificial intelligence (AI) landscape undergoes significant transformation, IQVIA Holdings finds itself at the forefront of this evolution.…